SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is experiencing volatility as the market digests the Federal Reserve's decision to cut interest rates by 25 basis points, with community sentiment split between bullish and bearish outlooks. Traders are actively debating whether this move signals a buying opportunity or the start of a larger correction, while closely watching for cues from Fed Chair Powell's statements. The discussion also includes concerns about the labor market, tariffs, and overall economic health.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid anticipation of the Federal Reserve's rate decision, with the market pricing in a cut. Community members are actively discussing potential market reactions, ranging from a post-announcement rally to a sell-the-news scenario, while also considering the broader economic implications and the Fed's future policy outlook.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum ($QBTS) is trending amidst excitement and speculation, with the stock recently reaching new highs. Community members are pointing to potential catalysts like rate cut cycles, government contracts, and advancements in quantum computing. Bullish sentiment is fueled by the anticipation of a short squeeze and the belief that quantum computing will revolutionize various industries, while some remain skeptical of the company's revenue prospects and valuation.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is experiencing volatility amid anticipation of the Fed's rate decision and discussion of potential future rate cuts, with community members debating whether small caps will benefit. Powell's remarks on labor market softening and economic growth are key talking points. Some traders are expressing concern about the overall market's reliance on a few mega-cap stocks.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending due to a recently announced $1.4 billion contract to build AI-powered data centers in Southeast Asia, with initial phases starting in late 2025. The community is actively debating the legitimacy of the deal and its potential impact on the company's valuation, especially in comparison to other AI-related stocks. Some investors believe this contract validates GRRR as an AI infrastructure play and anticipate significant growth, while others remain skeptical until further details and revenue figures are released.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders anticipate potential Fed rate cuts following recent economic data and await upcoming CPI and PPI reports, leading to discussions about recession risks and the bond market's next move. Community perspectives range from expectations of a bond rally to concerns about stagflation, with some highlighting the influence of tariffs and potential central bank actions. The conversation also involves analysis of technical indicators and potential trading strategies.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares

SOXS is trending as traders discuss its inverse relationship with the semiconductor sector, particularly regarding the performance of major holdings like NVDA and AVGO. Community sentiment suggests frustration with perceived manipulation and tracking errors within the ETF, especially when semiconductor stocks move in unexpected directions. Many are anticipating a market pullback or a hawkish stance from the Federal Reserve that could benefit the fund.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as investors anticipate the Fed's rate cut decision and its potential impact on crypto markets, with some expecting a bullish outcome and others bracing for a "sell the news" event. Community members are actively discussing potential price targets, the influence of rate cuts, and the performance of altcoins relative to Bitcoin. Broader discussions encompass Bitcoin's role as a store of value and its correlation with traditional markets.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crowd is excited about the possibility of "crow with knife" ($CAW.X) being listed on Coinbase, sparking a wave of bullish sentiment. The community emphasizes its fully circulated supply, strong organic community, and multichain functionality across $SOL.X, BSC, $CRO.X, and $ETH.X (BASE).

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending due to speculation around potential Fed rate cuts following weaker-than-expected jobs data, with the community debating whether this is a bull trap or a genuine signal for further market gains. Community members are closely watching upcoming inflation reports for further clues, while some express concern about the reliability of economic data. Debate continues about whether to "buy the dip" or prepare for a significant correction.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CorMedix Rallies 60% YTD: Is This an Indication to Buy the Stock?

CRMD stock surges nearly 60% YTD as DefenCath drives strong sales, boosted by a $300M Melinta acquisition deal and raised revenue outlook.

Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path?

CRMD's DefenCath, its only revenue source, posts $78.8M in sales in H1 2025, with exclusivity through 2033 fueling growth potential.

Is the Options Market Predicting a Spike in Amphastar Pharmaceuticals Stock?

Investors need to pay close attention to AMPH stock based on the movements in the options market lately.

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of +19.72% and +2.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BridgeBio Pharma (BBIO) Reports Q2 Loss, Beats Revenue Estimates

BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -14.46% and +14.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q2 Earnings? What You Should Know

Taysha Gene Therapies (TSHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for

Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bausch Health (BHC) Lags Q2 Earnings Estimates

Bausch (BHC) delivered earnings and revenue surprises of -7.22% and +2.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Amphastar Pharmaceuticals Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.85	--	--	N/A
Q2 '25	$0.74	$0.85	14.61%	BEAT
Q1 '25	$0.69	$0.74	7.77%	BEAT
Q4 '24	$0.94	$0.92	-1.95%	MISSED
Q3 '24	$0.99	$0.96	-2.83%	MISSED

AMPH
Amphastar Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest AMPH News

AMPH Amphastar Pharmaceuticals Inc